CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch (NASDAQ:GDTC)

Design Cells/iStock via Getty Images CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen receptor T-cell (“γδ CAR-T”) therapeutics for the treatment of cancer. The Company is one of many who are trying to exploit the body’s immune system to…

Read More